Stock Market

Market Snapshot: Chip Stocks Drive Indices, Geopolitical Stability Calms Oil and Bond Markets The global financial markets are experiencing upward momentum at midday, largely buoyed by a robust performance in the semiconductor sector. This positive sentiment permeates Wall Street as investors closely monitor developments surrounding a potential ceasefire between Iran and the United States, a … Read more

MaxLinear, Inc. (NASDAQ:MXL) recently saw its price target upgraded by financial firm Stifel, signaling continued confidence in the semiconductor company’s strategic direction and market position. On June 29, Stifel increased its target for MXL shares from $105 to $110, while maintaining a coveted “Buy” rating. This upward revision followed detailed discussions with MaxLinear’s senior management, … Read more

The artificial intelligence sector experienced a volatile trading session on Wednesday as investors aggressively purchased the dip in major memory chip stocks. Shares of Micron Technology (MU), SanDisk (SNDK), and Western Digital (WDC) all managed to trim earlier losses throughout the day, signaling a potential stabilization in market sentiment for hardware providers. Understanding the Market … Read more

Intuitive Machines, Inc. (NASDAQ:LUNR) is capturing significant investor attention. Following key NASA lunar lander awards, prominent financial firms like Craig Hallum and B. Riley have reiterated strong “Buy” ratings for the space exploration company. On July 1, Craig Hallum analyzed NASA’s latest Commercial Lunar Payload Services (CLPS) program awards, confirming they largely met market expectations. … Read more

Argus Research, in its report dated July 09, 2026, highlights The AES Corporation (AES) as a stock exhibiting a “high yield for a while.” With AES currently trading at $14.84 per share, this assessment warrants a closer examination of the company’s operational backbone and its position within the dynamic Utilities sector. Understanding the nuances of … Read more

Freedom Capital Initiates Coverage on Tempus AI (TEM) Freedom Capital has officially begun coverage of Tempus AI, Inc. (NASDAQ:TEM) with a ‘Hold’ rating, assigning a price target of $59 on July 1. This move positions Tempus AI, a prominent player in the rapidly expanding healthcare AI sector, under closer scrutiny from institutional investors. The firm’s … Read more

Exelixis (EXEL) Oncology Pipeline: A Closer Look at Clinical Performance Exelixis, Inc. (NASDAQ:EXEL), a prominent oncology biopharmaceutical company, navigates a complex landscape of drug development and regulatory milestones. The company’s recent disclosure on June 22 regarding its Phase 3 STELLAR 303 data has garnered investor attention, offering insights into its therapeutic candidates for metastatic colorectal … Read more

Bank of America (BofA) has adjusted its price target for Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), reducing it from $550 to $542. The firm has, however, maintained a Neutral rating on the biopharmaceutical company’s stock, signaling a cautious but not overtly pessimistic outlook. This revision primarily stems from an evolving perception of the market for Rezdiffra, Madrigal’s … Read more

Axsome Therapeutics (AXSM) Emerges as ‘Under-the-Radar’ Investment Leader Axsome Therapeutics, Inc. (NASDAQ:AXSM), a commercial-stage biopharmaceutical company, has recently captured significant market attention, cementing its position as one of the standout “under-the-radar” stocks for astute investors. The company specializes in developing innovative therapies tailored for managing central nervous system (CNS) disorders, a field with substantial unmet … Read more